血清25-羟基维生素D浓度与缺血性卒中及其亚型
该研究采用孟德尔随机化方法,利用MEGASTROKE联盟34 217例缺血性卒中病例和404 630例非病例的汇总数据,以6个单核苷酸多态性为工具变量(解释7.5%的血清25-羟基维生素D方差),分析遗传预测的血清25-羟基维生素D浓度与缺血性卒中及其亚型的因果关联。结果显示,遗传预测的血清25-羟基维生素D浓度升高与缺血性卒中及其各亚型均无显著关联。
要点
- 遗传预测的血清25-羟基维生素D每升高1个标准差(约18 nmol/L),全部缺血性卒中的OR为1.01(95%CI 0.94-1.08;P=0.84)。
- 大动脉粥样硬化性卒中OR为0.94(95%CI 0.80-1.11;P=0.49),小血管闭塞性卒中OR为0.95(95%CI 0.82-1.11;P=0.55)。
- 心源性栓塞性卒中OR为1.02(95%CI 0.90-1.16;P=0.74),敏感性分析结果相似。
核心结论
- 研究结果不支持较高的血清25-羟基维生素D浓度与任何缺血性卒中亚型存在因果关联,因此在一般人群中补充维生素D不太可能降低缺血性卒中风险。
研究设计与样本
- 采用孟德尔随机化设计,利用MEGASTROKE联盟的缺血性卒中汇总数据(34 217例病例和404 630例非病例)。
- 以6个与血清25-羟基维生素D浓度相关的单核苷酸多态性作为工具变量,这些位点解释7.5%的血清25-羟基维生素D方差,源自维生素D及高度相关性状的遗传决定因素研究联盟(n=79 366)。
- 主要分析采用逆方差加权法,并以加权中位数法、异质性惩罚法和孟德尔随机化-Egger法作为补充。
主要发现
- 基于全部6个单核苷酸多态性,遗传预测的血清25-羟基维生素D每升高1个标准差(约18 nmol/L),全部缺血性卒中的OR为1.01(95%CI 0.94-1.08;P=0.84)。
- 大动脉粥样硬化性卒中的OR为0.94(95%CI 0.80-1.11;P=0.49)。
- 小血管闭塞性卒中的OR为0.95(95%CI 0.82-1.11;P=0.55)。
- 心源性栓塞性卒中的OR为1.02(95%CI 0.90-1.16;P=0.74)。
- 敏感性分析结果与主要分析相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Observational studies have reported increased risk of ischemic stroke among individuals with low serum 25-hydroxyvitamin D (S-25OHD) concentrations but uncertainty remains about the causality of this association. We sought to determine whether S-25OHD concentrations are causally associated with ischemic stroke and its subtypes using Mendelian randomization. Methods- We used summary-level data for ischemic stroke (34 217 cases and 404 630 noncases) from the MEGASTROKE consortium. As instruments, we used 6 single nucleotide polymorphisms, explaining 7.5% of the variance in S-25OHD, previously identified to be associated with S-25OHD concentrations in the Study of Underlying Genetic Determinants of Vitamin D and Highly Related Traits consortium (n=79 366). The analyses were conducted using the inverse-variance-weighted method and complemented with the weighted median, heterogeneity-penalized, and Mendelian randomization-Egger approaches. Results- Genetically higher S-25OHD concentration was not associated with ischemic stroke. The odds ratios (95% CI) per genetically predicted 1-SD (≈18 nmol/L) increase in S-25OHD concentrations, based on all 6 single nucleotide polymorphisms, were 1.01 (0.94-1.08; P=0.84) for all ischemic stroke, 0.94 (0.80-1.11; P=0.49) for large artery stroke, 0.95 (0.82-1.11; P=0.55) for small vessel stroke, and 1.02 (0.90-1.16; P=0.74) for cardioembolic stroke. The results were similar in sensitivity analyses. Conclusions- These findings provide no support that higher S-25OHD concentrations are causally associated with any ischemic stroke subtype. Thus, vitamin D supplementation will unlikely reduce the risk of ischemic stroke in the general population.
引用
- Larsson SC, Traylor M, Mishra A, et al. Serum 25-Hydroxyvitamin D Concentrations and Ischemic Stroke and Its Subtypes. Stroke. 2018. PMID: 30355092. doi:10.1161/STROKEAHA.118.022242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。